Exciting advancements in brain imaging reveal how psychedelics like psilocybin can create lasting changes in brain activity, particularly in areas linked to mood regulation. Research shows that even after just one high dose, individuals experience enduring improvements in emotional well-being, highlighting the potential of these substances in treating refractory depression. The discussion also touches on ketamine's unique role as a rapid-acting antidepressant, particularly in acute situations.
